In Silico Mechanistic Modeling:
The Foundation of Precision Medicine

On Thursday June 29 2017, 3:00 pm EDT, for 1 Hour


* Limited registration only. Register before we're filled.

1-On-1 Consulting

The Need for a Revolution in Drug Discovery and Therapeutics Development

In Silico Mechanistic Modeling Shows the Way

The current trillion dollar pharmaceutical industry is in peril where the current drug development pipeline is slow, inefficient and incapable of being extended to multi-combination drug therapies as well as minimally focused on prevention.
Systems Biology has recognized that we are more than our genes. Disease and disfunctions emerge from the complex interplay of genes and proteins within complex molecular pathways.
The complex modeling of diseases and biological functions has been limited because of the inability to integrate large scale molecular pathways. Recent advances now provide breakthrough technology for doing scalable modeling of complex molecular systems.
In silico mechanistic modeling is no longer just theory. It is here and will revolutionize medicine. We will share many exciting examples on how in silico modeling is enabling drug discovery, multi-combination therapeutics, nutraceutical formulations as well as quantitative prediction of efficacy and toxicity.

Thursday, June 29, 2017

3:00 pm EDT

Duration 1 Hour

About The Host

Expert who will be conducting this webinar

Host Name

Dr. V. A. Shiva Ayyadurai, Ph. D.,

Chairman and CEO, CytoSolve, Inc.

Dr. V.A. Shiva Ayyadurai, the inventor of email and polymath, holds four degrees from MIT and is a world-renowned systems scientist. He is a Fulbright Scholar, Lemelson-MIT Awards Finalist, First Outstanding Scientist and Technologist of Indian Origin (STIO), Westinghouse Science Talent Honors Award recipient, and was nominated for the U.S. National Medal of Technology and Innovation. In 1982, the US government recognized Ayyadurai as the inventor of email by awarding him the first Copyright for “Email” at a time when Copyright was the only way to protect software inventions. His interest in human health also began early, when as a child, he observed his grandmother, a village farmer and healer, practice Siddha, India’s oldest system of traditional medicine. This motivated his future study and research in systems biology at MIT, leading to his discovery of Systems Health®, a major breakthrough that provides an integrative framework linking eastern and western medicine. His latest invention CytoSolve®, emerging from his doctoral research at MIT, provides a revolutionary platform for modeling complex biological phenomena, to support the development multi-combination medicines without animal testing.

You may visit his personal website at www.vashiva.com.









Who Should Attend this Seminar?

  • Disease Research Foundations

  • University Research Centers

  • Drug Development Companies

  • Biotechnology Companies

  • Nutritional Supplement Manufacturers

  • Functional Food Manufacturers

Any Questions?